Zydus signs MoU with Apollo Hospitals for multi-cancer early detection test
Zydus Lifesciences with Guardant Health, having an agreement to make the Shield™ Multi-Cancer Detection (MCD) test available in India, has signed a Memorandum of Understanding (MoU) with Apollo Hospitals to offer the test...
Cancer catching Indians at very early stage: Study
The average age for cancer diagnosis in India is much lower than to other nations like U.S., U.K., and China. The average age of diagnosis of breast cancer in India is 52 against 63 in the U.S. and UK, while for lung cancer...


